Government Ends OTC Sale of Cough Syrups, Prescription Now Mandatory
In a significant effort to enhance drug safety and protect public health, the Union Ministry of Health and Family Welfare has mandated that consumers obtain a doctor’s prescription before purchasing cough syrups and other syrup-based medicines. This new regulation comes in response to growing concerns regarding contamination cases linked to several cough syrup products in recent years.
The decision was officially announced through the Drugs (Fifth Amendment) Rules, 2026, which took effect on June 9 following its publication in the Official Gazette. The amendment removes the word “syrups” from Schedule K of the Drugs Rules, 1945. Previously, this schedule included certain medications that could be sold without a prescription under specific exemptions provided by the Drugs and Cosmetics Act.
As a result of this change, syrup-based medicines will no longer be available for over-the-counter purchase. Pharmacies across the country are now required to dispense these medicines only with a valid prescription issued by a registered medical practitioner.
The amendment follows a public consultation process that began in December 2025, during which draft rules were released for comments and suggestions. Government officials reviewed stakeholder feedback before issuing the final notification.
This decision comes in light of several incidents involving contaminated cough syrups produced in India. In recent years, these products have been linked to child deaths both in India and in countries like The Gambia and Uzbekistan. Another contamination case was reported in Cameroon, raising international concerns about drug quality and safety standards.
One of the most serious incidents occurred last year, when at least 22 children, primarily from Rajasthan, reportedly died after consuming contaminated cough syrup. Investigations revealed the presence of diethylene glycol (DEG), a toxic industrial chemical commonly found in antifreeze and brake fluid. Laboratory tests indicated DEG levels far exceeding permissible limits, posing severe risks to kidney and brain function.
Health authorities and the Central Drugs Standard Control Organisation (CDSCO) are currently examining measures to improve regulatory compliance and prevent similar incidents in the future.
Officials believe that the new prescription requirement will promote responsible use of syrup-based medicines, enhance monitoring of drug sales, and strengthen patient safety. While this regulation may slightly alter how consumers access common cough medicines, the government emphasizes that the primary goal is to mitigate health risks and restore confidence in the safety of the country’s pharmaceutical framework.
